porfiromycin has been researched along with Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BOSTWICK, L; EVANS, JS; MENGEL, GD | 1 |
| Adams, GE; Stratford, IJ | 1 |
| Kuehl, BL; Marshall, RS; Rauth, AM | 1 |
| Carter, SK; Muggia, FM; Rozencweig, M; Slavik, M | 1 |
| Grage, TB; Reynolds, V; Weiss, AJ; Wilson, W | 1 |
| Marshall, RS; Paterson, MC; Rauth, AM | 1 |
| Braunschweiger, PG; Furmanski, P; Johnson, CS; Jones, SA | 1 |
| al-Sarraf, M; Izbicki, R; Reed, ML; Vaitkevicius, VK; Vaughn, CB | 1 |
1 review(s) available for porfiromycin and Neoplasms
| Article | Year |
|---|---|
Cellular approaches to bioreductive drug mechanisms.
Topics: Animals; Antineoplastic Agents; CHO Cells; Cricetinae; Humans; Mitomycin; Neoplasms; Oxidation-Reduction; Oxygen; Porfiromycin | 1993 |
1 trial(s) available for porfiromycin and Neoplasms
| Article | Year |
|---|---|
Further clinical trials with porfiromycin (NSC-56410) (large intermittent doses).
Topics: Adenocarcinoma; Adult; Anemia; Astrocytoma; Blood Cell Count; Blood Platelets; Carcinoma; Carcinoma, Squamous Cell; Child; Clinical Trials as Topic; Cystadenoma; Female; Humans; Leukocyte Count; Neoplasms; Osteosarcoma; Porfiromycin; Rhabdomyosarcoma | 1972 |
6 other study(ies) available for porfiromycin and Neoplasms
| Article | Year |
|---|---|
SYNERGISM OF THE ANTINEOPLASTIC ACTIVITY OF CYTOSINE ARABINOSIDE BY PORFIROMYCIN.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Body Weight; Cytarabine; Cytosine; Leukemia; Leukemia L1210; Leukemia, Experimental; Mice; Mitomycin; Mitomycins; Neoplasms; Neoplasms, Experimental; Nucleosides; Pharmacology; Porfiromycin; Research; Survival | 1964 |
Bioreductive drugs for cancer therapy: the search for tumor specificity.
Topics: Animals; Antineoplastic Agents; Humans; Neoplasms; Nitric Oxide; Nitroimidazoles; Oxidation-Reduction; Photochemotherapy; Porfiromycin; Prodrugs; Tirapazamine; Triazines | 1994 |
Overview of early and investigational chemotherapeutic agents in solid tumors.
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Aziridines; Azo Compounds; Camptothecin; Cycloleucine; Etoposide; Floxuridine; Humans; Neoplasms; Nitrogen Mustard Compounds; Picolinic Acids; Platinum; Porfiromycin; Streptonigrin; Teniposide; Thiotepa; Tubercidin | 1976 |
Phase I studies of porfiromycin (NSC--56410) in solid tumors.
Topics: Drug Evaluation; Humans; Leukopenia; Necrosis; Neoplasms; Porfiromycin; Thrombocytopenia | 1975 |
Studies on the mechanism of resistance to mitomycin C and porfiromycin in a human cell strain derived from a cancer-prone individual.
Topics: Cell Line; Cell Survival; Child; Drug Resistance; Female; Glutathione; Humans; Kinetics; Mitomycin; Mitomycins; NAD(P)H Dehydrogenase (Quinone); Neoplasms; Oxygen; Porfiromycin; Precipitin Tests; Quinone Reductases; Tumor Cells, Cultured | 1991 |
Potentiation of mitomycin C and porfiromycin antitumor activity in solid tumor models by recombinant human interleukin 1 alpha.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Interleukin-1; Ketoconazole; Mice; Mice, Inbred C57BL; Mitomycin; Neoplasms; Porfiromycin; Recombinant Proteins; Tumor Cells, Cultured | 1991 |